Residency · Residency · Pathology
Renal Biopsy Interpretation: Light, IF, and EM
Introduction
Renal biopsy interpretation requires the integrated analysis of light microscopy (LM), immunofluorescence (IF), and electron microscopy (EM). This trimodal approach is essential for accurate classification of glomerular, tubulointerstitial, and vascular diseases and directly informs treatment decisions.
Specimen Handling and Processing
Biopsy Adequacy
A minimum of 10 glomeruli is needed for adequate evaluation (some guidelines accept 8), and fewer than 5 glomeruli significantly limits diagnostic confidence. Two cores are preferred: one for LM and special stains, and one divided for IF and EM. Cortex must be sampled, as medulla-only biopsies are inadequate for glomerular disease assessment.
Tissue Allocation
Light microscopy tissue is formalin-fixed and paraffin-embedded, with stains including H&E, PAS, trichrome (Masson or Jones silver), and Congo red if amyloid is suspected. Immunofluorescence tissue is snap-frozen in OCT for direct IF with IgG, IgA, IgM, C3, C1q, kappa, lambda, and fibrinogen, with additional markers as needed. Electron microscopy tissue is fixed in glutaraldehyde, with thin sections stained with uranyl acetate and lead citrate. IF on paraffin-embedded tissue using pronase digestion is an alternative when frozen tissue is unavailable.
Special Stains in Renal Pathology
PAS highlights basement membranes, mesangial matrix, and tubular brush borders. Jones methenamine silver (JMS) is the best stain for basement membrane detail, revealing spikes, double contours, and holes. Masson trichrome differentiates collagen (blue/green) from fibrinoid (red) and identifies fibrosis and crescents. Congo red detects amyloid with apple-green birefringence under polarized light.
Systematic Approach to Light Microscopy
Glomerular Evaluation
Cellularity is assessed for mesangial hypercellularity (more than 3 mesangial cells per mesangial area), endocapillary proliferation, and extracapillary proliferation (crescents). Basement membrane changes include thickening, splitting, double contours (tram-tracking), and spikes. Sclerosis is categorized as segmental (part of tuft) versus global (entire tuft), and the percentage of globally sclerotic glomeruli is recorded. Deposits may be subepithelial, subendothelial, mesangial, or intramembranous, best confirmed on EM. Crescents are classified as cellular, fibrocellular, or fibrous, with the percentage of glomeruli involved documented.
Tubulointerstitial Evaluation
Tubular injury includes acute tubular injury (ATI), epithelial flattening, brush border loss, and casts. Interstitial inflammation is assessed for location, composition (lymphocytes, plasma cells, eosinophils, neutrophils), and tubulitis. Interstitial fibrosis and tubular atrophy (IFTA) is reported as a percentage of involvement and correlates with long-term renal prognosis. Casts are characterized as red cell casts (glomerulonephritis), WBC casts (pyelonephritis), hyaline casts, or waxy casts.
Vascular Evaluation
Arteriosclerosis is characterized by intimal fibrosis and graded as mild, moderate, or severe. Arteriolar hyalinosis presents as insudative hyaline deposits and is associated with hypertension and diabetes. Thrombotic microangiopathy (TMA) features fibrin thrombi, endothelial swelling, fragmented red blood cells, and mucoid intimal edema. Vasculitis shows fibrinoid necrosis and inflammation of vessel walls.
Immunofluorescence Patterns
Key Patterns
Linear GBM staining for IgG is the hallmark of anti-GBM disease (Goodpasture), showing bright, smooth, linear IgG along capillary walls. Granular immune complex deposition is seen in membranous nephropathy (subepithelial granular IgG and C3), lupus nephritis, and post-infectious glomerulonephritis. Mesangial IgA dominant staining is characteristic of IgA nephropathy, with IgA plus or minus C3 in the mesangium. A full house pattern (IgG, IgA, IgM, C3, C1q) is characteristic of lupus nephritis. C3 dominant staining with absent or scant immunoglobulin indicates C3 glomerulopathy (dense deposit disease or C3 glomerulonephritis), which is complement-mediated. Pauci-immune patterns (negative or minimal IF) are seen in ANCA-associated vasculitis and crescentic glomerulonephritis. Kappa or lambda light chain restriction indicates monoclonal immunoglobulin deposition disease, light chain cast nephropathy, or amyloidosis.
| IF Pattern | Key Staining | Associated Disease(s) |
|---|---|---|
| Linear IgG on GBM | Bright, smooth IgG along capillary walls | Anti-GBM disease (Goodpasture) |
| Granular capillary wall | IgG, C3 in granular pattern | Membranous nephropathy, lupus, post-infectious GN |
| Mesangial IgA dominant | IgA ± C3 in mesangium | IgA nephropathy, HSP nephritis |
| Full house | IgG, IgA, IgM, C3, C1q | Lupus nephritis |
| C3 dominant | C3 without significant Ig | C3 glomerulopathy (DDD, C3GN) |
| Pauci-immune | Negative or minimal staining | ANCA-associated vasculitis |
| Light chain restriction | Kappa or lambda restricted | MIDD, cast nephropathy, amyloidosis |
IF Interpretation Pitfalls
Nonspecific trapping of immunoglobulins occurs in sclerotic glomeruli. Mesangial IgM is often nonspecific. Weak C3 staining in arteriolar walls may be nonspecific. IF findings should always be correlated with LM and EM.
Electron Microscopy Findings
Deposit Location and Significance
Subepithelial deposits are seen in membranous nephropathy (PLA2R-associated or secondary), appearing as dense deposits along the outer GBM with spike formation. Subendothelial deposits occur in lupus nephritis (Class III/IV), membranoproliferative glomerulonephritis, and cryoglobulinemic glomerulonephritis. Mesangial deposits are found in IgA nephropathy and lupus nephritis (Class I/II). Intramembranous dense deposits characterize dense deposit disease (C3 glomerulopathy), presenting as ribbon-like osmiophilic deposits within the GBM. Organized deposits include fibrillary deposits (fibrils approximately 20 nm), immunotactoid deposits (microtubules greater than 30 nm), and amyloid (fibrils 8-12 nm, randomly arranged).
| Deposit Location | Associated Diseases | EM Appearance |
|---|---|---|
| Subepithelial | Membranous nephropathy, post-infectious GN (humps) | Dense deposits outer GBM, spike formation |
| Subendothelial | Lupus III/IV, MPGN, cryoglobulinemic GN | Deposits inner GBM, double contours |
| Mesangial | IgA nephropathy, lupus I/II | Deposits in mesangial matrix |
| Intramembranous | Dense deposit disease (C3 glomerulopathy) | Ribbon-like osmiophilic deposits within GBM |
| Organized (fibrillary) | Fibrillary GN | Fibrils ~20 nm, randomly arranged |
| Organized (immunotactoid) | Immunotactoid GN | Microtubules >30 nm, parallel arrays |
| Organized (amyloid) | AL/AA amyloidosis | Fibrils 8–12 nm, randomly arranged |
Podocyte and GBM Findings
Podocyte foot process effacement is the hallmark of minimal change disease (diffuse, greater than 80%) and is also present in FSGS and other proteinuric diseases. GBM thinning characterizes thin basement membrane nephropathy (typically less than 250 nm) and may overlap with early Alport syndrome. GBM lamellation and basket-weaving with splitting of the lamina densa is seen in Alport syndrome. Endothelial tubuloreticular inclusions are associated with interferon-alpha activation and seen in lupus nephritis and HIV nephropathy.
Major Glomerular Diseases: Integrated Diagnosis
IgA Nephropathy
On LM, mesangial hypercellularity is present, and segmental sclerosis or crescents may be seen in severe cases. IF shows dominant mesangial IgA with co-dominant C3 plus or minus IgG/IgM. EM reveals mesangial electron-dense deposits with occasional subendothelial deposits in severe cases. The Oxford classification (MEST-C) grades Mesangial hypercellularity, Endocapillary proliferation, Segmental sclerosis, Tubular atrophy/interstitial fibrosis, and Crescents.
Membranous Nephropathy
On LM, diffuse GBM thickening is seen, and the silver stain shows subepithelial spikes. IF demonstrates granular capillary wall IgG and C3, often of the IgG4 subclass, with PLA2R staining positive in approximately 70% of primary cases. EM shows subepithelial deposits in various stages (I-IV Ehrenreich-Churg). Secondary causes include lupus, hepatitis B, malignancy, and drugs.
Lupus Nephritis
The ISN/RPS classification spans Class I (minimal mesangial) through Class VI (advanced sclerosis). Class III (focal) involves less than 50% of glomeruli with endocapillary or extracapillary proliferation. Class IV (diffuse) involves more than 50% of glomeruli and is the most severe proliferative form. Class V (membranous) shows subepithelial deposits and may coexist with Class III or IV. The full-house IF pattern is characteristic, and tubuloreticular inclusions are seen on EM.
Minimal Change Disease and FSGS
Minimal change disease shows normal LM, negative IF, and diffuse foot process effacement on EM. FSGS demonstrates segmental sclerosis in some glomeruli, with perihilar and tip variants carrying a better prognosis and the collapsing variant (associated with HIV and APOL1) being most aggressive. The Columbia classification of FSGS includes collapsing, tip, cellular, perihilar, and not otherwise specified (NOS) variants.
Clinical Pearls
Adequate renal biopsy tissue must be properly allocated among light microscopy, immunofluorescence, and electron microscopy; omission of any modality compromises diagnostic accuracy. The Jones methenamine silver stain is the most informative special stain for evaluating glomerular basement membrane changes including spikes, double contours, and holes. Full-house immunofluorescence (positive IgG, IgA, IgM, C3, and C1q) is characteristic of lupus nephritis but must be correlated with clinical and serologic findings. Electron microscopy is essential for definitive diagnosis of minimal change disease (foot process effacement with otherwise normal biopsy) and for characterizing the ultrastructure of organized deposits.
References
- Fogo AB, et al. Fundamentals of Renal Pathology. 2nd ed. Springer; 2014.
- Sethi S, et al. A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int. 2017;91(4):787-789.
- Trimarchi H, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014-1021.
- Bajema IM, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis. Kidney Int. 2018;93(4):789-796.